- Home
- HLXB vs CLLS Comparison
HLXB vs CLLS Comparison
Compare HLXB & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLXB
- CLLS
- Stock Information
- Founded
- HLXB 2021
- CLLS 1999
- Country
- HLXB United States
- CLLS France
- Employees
- HLXB N/A
- CLLS N/A
- Industry
- HLXB
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- HLXB
- CLLS Health Care
- Exchange
- HLXB NYSE
- CLLS Nasdaq
- Market Cap
- HLXB 245.7M
- CLLS 240.2M
- IPO Year
- HLXB 2024
- CLLS 2007
- Fundamental
- Price
- HLXB $10.80
- CLLS $1.57
- Analyst Decision
- HLXB
- CLLS Buy
- Analyst Count
- HLXB 0
- CLLS 3
- Target Price
- HLXB N/A
- CLLS $7.00
- AVG Volume (30 Days)
- HLXB 12.4K
- CLLS 56.7K
- Earning Date
- HLXB 01-01-0001
- CLLS 11-04-2024
- Dividend Yield
- HLXB N/A
- CLLS N/A
- EPS Growth
- HLXB N/A
- CLLS N/A
- EPS
- HLXB N/A
- CLLS N/A
- Revenue
- HLXB N/A
- CLLS $36,042,000.00
- Revenue This Year
- HLXB N/A
- CLLS $271.02
- Revenue Next Year
- HLXB N/A
- CLLS $33.48
- P/E Ratio
- HLXB N/A
- CLLS N/A
- Revenue Growth
- HLXB N/A
- CLLS 46.96
- 52 Week Low
- HLXB $10.03
- CLLS $1.53
- 52 Week High
- HLXB $10.99
- CLLS $3.55
- Technical
- Relative Strength Index (RSI)
- HLXB N/A
- CLLS 27.91
- Support Level
- HLXB N/A
- CLLS $1.85
- Resistance Level
- HLXB N/A
- CLLS $2.09
- Average True Range (ATR)
- HLXB 0.00
- CLLS 0.09
- MACD
- HLXB 0.00
- CLLS -0.04
- Stochastic Oscillator
- HLXB 0.00
- CLLS 0.00
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.